Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

25. September 2016 20:20 ET | Quelle: Galapagos NV

Endoscopic improvements with filgotinib are consistent with clinical remission rates in patients with Crohn's disease

MECHELEN, Belgium, Sept. 25, 2016 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext & NASDAQ: GLPG) reports that Dr Severine Vermeire, principal investigator of the FITZROY Phase 2 study with investigational...
28. April 2016 16:13 ET | Quelle: Galapagos NV

Galapagos kick-starts 2016 with Q1 cash position of EU988 M

First quarter financial results: Group revenues €14.8 M Group net profit €35.9 M End of first quarter cash €987.6 M, including €9.3 M in...
03. April 2016 16:29 ET | Quelle: Galapagos NV

Galapagos increases share capital through warrant exercises

MECHELEN, Belgium, April 3, 2016 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 131,695 new...
25. März 2016 17:06 ET | Quelle: Galapagos NV

Publication of the annual report and invitation to the Annual and Extraordinary Shareholders' Meetings

Mechelen, Belgium, March 25, 2016 (GLOBE NEWSWIRE) -- Today Galapagos NV (Euronext & NASDAQ: GLPG) has published its Annual Report for the financial year 2015. The Annual Report for the...
19. Januar 2016 17:02 ET | Quelle: Galapagos NV

Galapagos and Gilead complete closing of their global collaboration for filgotinib

MECHELEN, Belgium and FOSTER CITY, Calif., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext & NASDAQ: GLPG) and Gilead Sciences, Inc. (NASDAQ:GILD) announced today the closing and entry...
21. November 2015 07:27 ET | Quelle: Galapagos NV

Invitation to the Special Shareholders' Meeting of Galapagos on 22 December 2015

MECHELEN, Belgium, Nov. 21, 2015 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext & NASDAQ: GLPG) has the honor to invite the Shareholders, Warrant Holders, Directors and Statutory Auditor of the...
20. November 2015 01:40 ET | Quelle: Galapagos NV

Galapagos initiates Phase 1 First-in-Human study with GLPG1972, receives EU3.5 million milestone from Servier

MECHELEN, Belgium, Nov. 20, 2015 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext & NASDAQ: GLPG) announced today that GLPG1972, a first-in-class candidate drug aiming at treating osteoarthritis, has...
12. November 2015 16:12 ET | Quelle: Galapagos NV

Galapagos reports third quarter 2015 cash position of EU374 M

Financial results of the first nine months: Group revenues €47.2 M Group net loss €61.4 M, reflecting planned increase in pipeline investment End of third...
02. Oktober 2015 16:16 ET | Quelle: Galapagos NV

Galapagos raises EU1.2 million through warrant exercises

MECHELEN, Belgium, Oct. 2, 2015 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext & NASDAQ: GLPG) announced a share capital increase arising from warrant exercises. As a result of warrant exercises,...
19. Juni 2015 16:07 ET | Quelle: Galapagos NV

Galapagos raises EU4.4 million through warrant exercises

MECHELEN, Belgium, June 19, 2015 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext:GLPG) (Nasdaq:GLPG) announced today a share capital increase arising from warrant exercises. Since its inception in 1999,...

Nächste Seite